NeuroVive reallocate research resources from the Asian subsidiary of the parent company
NeuroVive Pharmaceutical AB , a company in mitochondrial medicine announced that research resources and activities of the Taiwan-based subsidiary redirected to the parent company...
Jitsubo and Japanese pharma company Enter License Agreement and Collaboration for cardiovascular disease
Jitsubo Co., Ltd. announced that it has executed the joint development and license agreement with a Japanese pharmaceutical company (undisclosed) on JIT-2001 (development code)...
COPD Biomarker Qualification Consortium Partners with Bio-Techne to Identify COPD Indicator
The COPD Foundation-sponsored COPD Biomarker Qualification Consortium announced that it has partnered with the Bio Techne Cor, a manufacturer of biotechnology products for life...
Adaptive Biotechnologies, Amgen partner to develop sequencing-based ALL assay
Adaptive Biotechnologies, the leader in combining next-generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the adaptive immune system, announces...
Sanofi Pasteur and Msd end joint vaccines business in Europe
Sanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known as Merck & Co....
Sun Pharma & Moebius Medical sign deal to develop novel liposomal non-opiod pain product
Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) and Israel-based Moebius Medical have entered into an exclusive worldwide licensing deal to...
The European Commission Grants VAL001 Orphan Drug Designation for the Treatment of Diffuse Large B-cell Lymphoma
Respiratorius AB (publ.) has received Orphan Drug Designation for its drug candidate VAL001 following a decision by the European Commission. VAL001 will at product...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...